Chapter
The Opioid Crisis
51:58 - 57:27 (05:29)
The rise of opioid addiction in America, specifically regarding Oxycontin and Purdue Pharma's involvement, including their attempts to classify the drug as uncontrolled in order to increase prescriptions and profits.
Clips
Purdue Pharma, makers of OxyContin, released a new formulation of the medication after several oxycontin patents expired and managed to ban the selling of generic oxycontin.
51:58 - 53:34 (01:36)
Summary
Purdue Pharma, makers of OxyContin, released a new formulation of the medication after several oxycontin patents expired and managed to ban the selling of generic oxycontin. The drug became prone to abuse and as a result, addicts turn to cheaper alternatives like heroin.
ChapterThe Opioid Crisis
EpisodePart One: The Sackler Family: America's Deadliest Drug Dealers
PodcastBehind the Bastards
Executives from Purdue Pharma discussed plans to convince German officials to classify Oxycontin, making it easier to prescribe without patient consultation.
53:34 - 55:37 (02:02)
Summary
Executives from Purdue Pharma discussed plans to convince German officials to classify Oxycontin, making it easier to prescribe without patient consultation. A similar program in Denmark that provides free heroin to addicts has shown reduced crime rates and no increase in addiction.
ChapterThe Opioid Crisis
EpisodePart One: The Sackler Family: America's Deadliest Drug Dealers
PodcastBehind the Bastards
Richard asks if it's possible to appeal Germany's decision to treat Oxycontin as any other addictive narcotic and discusses how Germany has strict rules on video games.
55:37 - 57:27 (01:50)
Summary
Richard asks if it's possible to appeal Germany's decision to treat Oxycontin as any other addictive narcotic and discusses how Germany has strict rules on video games.